Patent · US Expired

Radiation therapy using a radioactive implantable device and a radiosensitizer agent

US6547812B1 · kind B1 · utility

26Cited by
41References
57Claims
0Family size

Assignee

Inventor

  • Ty Hu · Mountain View, US

Key dates

Filing dateDec 29, 2000
Grant dateApr 15, 2003
Priority date
Expiry dateMar 16, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61F2210/0095
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method and apparatus for inhibiting vascular restenosis using a radioactive implantable medical device and a radiosensitizer agent. In one embodiment, the method of the invention includes implanting a medical device at a blood vessel site that has undergone a procedure to open a stenosed region within a blood vessel. The medical device contains a radioisotope to emit a radioactivity to a tissue mass at the blood vessel site. The method further includes delivering a radiosensitizer agent to the tissue mass at the blood vessel site. The radiosensitizer agent increases a therapeutic response of the tissue mass to the radioactivity emitted by the radioisotope.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.